Is Zeria Pharmaceutical Co., stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Zeria Pharmaceutical Co., pays dividends. Last time was Sunday 1st of December 2024 where the investors holding the stock on Friday 27th of September 2024 were paid JPY23 per share. Over the last 48 times between 2001 and 2024, Zeria Pharmaceutical Co., has paid JPY618.7273 with an average of JPY12.89 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Zeria Pharmaceutical Co., 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY1 885.00, you would have made a profit of JPY367.00 per share or 19.47%
Yes, the average daily trading liquidity for Zeria Pharmaceutical Co., is JPY52 449 thousand. You should therefore be able to get in and out of your positions relatively fast.
Zeria Pharmaceutical Co., has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.22, the company's ability to pay off the debt is normal. Zeria Pharmaceutical Co., has a good net profit margin of 10.21% and should have high tolerances against inflation.
We have calculated the inflation risk for Zeria Pharmaceutical Co., to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.